PMA
P920023: UROLUME ENDOPROSTHESIS
FDA PMA · STENT, URETHRAL, BULBOUS, PERMANENT OR SEMI-PERMANENT · Boston Scientific Corp
Key facts
| PMA number | P920023 |
|---|---|
| Trade name | UROLUME ENDOPROSTHESIS |
| Generic name | STENT, URETHRAL, BULBOUS, PERMANENT OR SEMI-PERMANENT |
| Applicant | Boston Scientific Corp |
| Owner/operator | Boston Scientific Corporation |
| Product code | MES |
| Approval date | May 6, 1996 |
| Docket number | 96M-0356 |
| Notice date | Oct 9, 1996 |
| Establishment registration | 3005099803 |
| FEI number | 3005099803 |
At a glance
- 10–99 Supplements
- Aug 2, 2012 Latest supplement decision
- Yes Withdrawn
- No Summary of safety and effectiveness on file
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: